Ahead of meetings with investors, CVS Health (NYSE:CVS) discloses that its previously issued (May 6) earnings and cash flow guidance for the year will remain unchanged.
EPS: $5.47 – 5.60.
Non-GAAP EPS: $7.04 – 7.17.
Cash flow ops: $10.5B – 11.0B.
All other guidance withdrawn on May 6 remains so.
https://seekingalpha.com/news/3581856-cvs-stays-course-2020-outlook
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.